返回
化工社化工社化学信息打印报告 · 仅供科研参考
HRID 38607生成日期:2026年10月26日

哌嗪-1-羧酸二甲胺 → 4-[(2E)-4-{4-[(3-Chloro-5-hydroxyphenyl)amino]-5,8-dihydropyrido[4',3':4,5]thieno[2,3-d]-pyrimidin-7(6H)-yl}-4-oxobut-2-en-1-yl]-N,N-dimethylpiperazine-1-carboxamide

https://huagongshe.com/reaction/38607

反应方程式

参与物

角色名称HCID投料
反应物哌嗪-1-羧酸二甲胺HCID 712909—
反应物4-溴巴豆酸HCID 6436411—
反应物3-Chloro-5-(5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-ylamino)phenol hydrochlorideHCID 66850088—
产物4-[(2E)-4-{4-[(3-Chloro-5-hydroxyphenyl)amino]-5,8-dihydropyrido[4',3':4,5]thieno[2,3-d]-pyrimidin-7(6H)-yl}-4-oxobut-2-en-1-yl]-N,N-dimethylpiperazine-1-carboxamideHCID 58116972—

反应步骤

In analogy to Example 130, the title compound was prepared from (2E)-4-bromobut-2-enoic acid (84 mg, 0.41 mmol), 3-chloro-5-(5,6,7,8-tetrahydropyrido[4′,3′:4,5]thieno[2,3-d]pyrimidin-4-ylamino)phenol hydrochloride from Example 65A (100 mg, 0.27 mmol) and N,N-dimethylpiperazine-1-carboxamide (68 mg, 0.43 mmol) to yield 59 mg (38%).

来源与证据

DOI10.6084/m9.figshare.5104873.v1
专利号US08524722B2
来源数据集uspto-grants-2013_09
ORD IDord-1ba13dacd352496a8ab6b199f4a36e8f
来源说明uspto-grants-2013_09